OSLO, 13 June 2025: EXACT Therapeutics AS (“EXACT-Tx”, “the Company” Euronext Growth: EXTX) held its Annual General Meeting on June 13, 2025 at 10:30 CEST.
All proposed resolutions were approved.
Please find enclosed the minutes of the meeting including appendices. The minutes will also be available on the company website: www.exact-tx.com
For more information, please contact:
Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com
John M. Edminson CFO
EXACT Therapeutics
Email: john.edminson@exact-tx.com
About EXACT-Tx:
EXACT-Tx is a clinical-stage precision medicine company utilizing the power of ultrasound and microbubbles to enable targeted drug delivery in oncology. Acoustic Cluster Therapy (ACT®) follows a unique approach and may be applied to a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy) and brain diseases. www.exact-tx.com